REMINDER: Our user survey closes on Friday, please submit your responses here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Operating highlights of the year 2009/10 was another good year across the System C Group. § Our major investment in next-generation Medway products is being rewarded. The Group now has a rich suite of health and social care products which is attracting significant customer interest and key strategic contract wins. Group product revenues increased by 215% over the year to £20.6m, of which £13.9m was attributable to organic growth. § Our reputation for deploying systems - both our own and systems from third parties - on time and to budget led to strong demand for our services work from existing and new clients. Services revenues increased by 16% over the year to £17.8m, of which £17.6m was attributable to organic growth. § The Group's reputation for advanced technology and for successful deployments was further enhanced when it was named world-wide winner of the prestigious 2010 Microsoft Partner of the Year award in the category 'Public Sector Health Partner'. System C won the award for its Clinical Dashboard products, developed and implemented over the course of the year in over a dozen NHS Trusts. § In July 2009, System C acquired Liquidlogic Limited to create the UK's first major health and social services supplier. The two companies have started integrating products and have produced the UK's first health and social care link under the NHS Connecting for Health's new standards for systems integration. Since the year-end, the new Government has announced that it will be going out to consultation on how best to integrate health and social care. System C is uniquely placed to meet this national drive for high quality integrated care
Financial highlights of the year § Revenues increased by 75% to £38.3m (2009: £21.9m). Revenues excluding those from current year acquisitions increased by 44% to £31.5m (2009: £21.9m) § Profit before taxation up 32% to £5.4m (2009: £4.1m) § EPS up 9% at 4.07 pence (2009: 3.72p) § Strong cash generation with a net cash position as at 31 May 2010 of £18.6m (2009: £14.7m) § Major investment in next-generation Medway products rewarded with key strategic contract wins § Acquisition of Liquidlogic Limited in July 2009 for a total consideration of £10.2m giving System C entry into the social care IT market § Acquisition of Conscia Enterprise Systems Limited in October 2009 for a total consideration of £0.8m, strengthening the Group's expertise in web-based technologies § Total dividend increased by 14% to 0.75p for the full year Dr Ian Denley, Chief Executive of System C, commented: "We are pleased to have turned in another strong performance across the Group over the period. "This is a time of great upheaval for the NHS, in both policy and economic terms, with changes underway that are generating both risks and opportunities. "At System C, we are completing our 5-year strategic investment in our Medway software and bringing the products to market at a time when NHS Trusts have been newly freed from central purchasing obligations. We are now experiencing a surge in procurement activity, and have already achieved strategic contract wins, including The Royal Devon & Exeter NHS Foundation Trust. "As stated in our recent trading update, services revenues are down but holding steady and the sales pipeline for Medway has never been stronger. We are expecting PAS/EPR procurements to complete during the next calendar year and Medway revenues are already starting to come through." "We are very excited about these new product opportunities, and believe they will provide us with increased predictability of revenues and an excellent platform for growth next year and beyond ".
http://www.investegate.co.uk/Article.aspx?id=201009270700153152T
Well this was always well over sold :) 32.50 - 34.50
just bought 10k @ 34p - at best. couldn't buy live - had to place an indicative order
Yes had seen that mate thanks :)
Others agree and that this is now over sold as the buys are starting to come back in :) 26 - 27.5
Well yes things have been cut back as we knew they would be but this is still a great company and has a good strong future, this must almost be getting to a great buying opp for me again now but will see how we go.......:) 25 - 27.5
Big drop on here over the last 2 weeks , just wondered if you had any ideas to why. The only thing thats changed since I bought in was the sell off by Blackrock of some of their holdings. The RNS is soon and they are promising good things. My only concern is the govt possible cuts in the NHS. Could it be an MMs play?
Does anybody know the reason for the drop? I've been searching and can't find any reason! Is it to do with the below quote? "The Directors recognise that in the short term, government spending cuts present a risk to revenues, particularly services revenues. The timing of NHS procurements and deployments will have a significant impact on the Company's performance during the current year..." http://www.investegate.co.uk/Article.aspx?id=201006150700176027N
for what might be a stupid question. But just a few weeks ago there was some signifcant sustained big buys. As soon as they stopped the price has dropped. Any chance all those buys were really sells??
Yes agree mate, these prices are not going to be about for long...... Just wish I had some spare to top up with......
This is at a bargain price now and a steal if buying in. The company has no debts and revenue has grown for the last 3 years. A relatively small amount of shares in issue and cash in the bank. Several procurement deals are due to be added to this years end of year report which is expected to show further growth. Looking at delayed trades we have 120 K s worth of buys to be added against 9 Ks worth of sells. Being played at present.
Some delayed trades here to add to the mix. Looking at the times off purchase I am guessing that the 79,000 and the 8800 are buys and the 20,000 is a sell. Could see this move up when added as it does move on small PI purchases rather than investment company purchases. Lets hope the whole market bounces and we can see this rise with it.
Time to get in here if not invested yet. The end of year statement is due on September 27th and results are expected to be excellent. Pre Tax profits are in line to be 5.4 Million and revenue is expected to have increased by 75% from last years results. The company has attained 2 new contracts in the last year with the NHS and they are expected to be completed by end of this month. May see a trading statement before results. This should start to climb in the next few weeks but as always DYOR.
Was up at pre open for a bit of MM skullduggery but the price back to last close price, 39.0-40.0. This should start to move over the next few weeks as we approach report time. Remember they are expecting to post a revenue increase of 75% in September. I am also expecting to see some TUs regarding contracts for the Medway suite from various health authorities who have shown interest.GLA
Here today now at full ask :) 39 - 40
Very frustrating to see the spread drop the SP after a spell of PI buys yesterday. Slightly manipulated I would say, we had less private buying last week but saw a rise , no sense in this at all.
Nice buying here again today by PI's and not II this time I would say......
Yes looks like the buys are starting to increase now so hopefully more good news soon :)
Good start today but a strange range of buy prices, surely not volatility in this share! Lets keep this up and hope for a little tick up early on.
Yes ,Searcher looking like some old trades could push us in the right direction again. Only wish they could put them on the books at open,as on Barx the SP has stayed static, it gives investors confidence when they see an immediate tick up.
With a delayed buy for 192,000 at 42.5..... Which is above the full ask :)
Thanks for the feedback guys. I was thinking around the 60p mark before I do anything but the question is do I sell 50-75% of my original investment at 60p and leave the rest long term, 3-5 years or do I take the profit while it's there. What are your long term aspirations?
The end of year results are due in mid/late september so I would expect that this is creating the slow rise at present.The board are also saying that revenue increase here will be around 75% come the report so that is a real big deal as far as SPs are concerned. The rise seems to be slow but steady, adding .25/.50 a day on average so I would think we will be at high 50s possible low 60s by the RNS in September.This is just my own views so dont take it as gospel, but things are looking rosey here!